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1. Introduction 
1.1 The burden of complex arrhythmias 
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 9% of the 
population over 70 years of age (Feinberg, Blackshear et al. 1995). It is characterised by an 
irregular pulse, leading to symptoms of shortness of breath, dizziness, palpitations, chest 
pain, lethargy and an increased risk of stroke (Kannel, Abbott et al. 1982).  Current widely 
accepted indications for catheter ablation of AF are significant symptoms uncontrolled by 
anti-arrhythmic medications, however more recent European Guidelines have suggested 
catheter ablation may be used as a first line treatment for symptomatic paroxysmal AF in 
patients with no or minimal heart disease. Randomised trials from 2003 - 2010 have shown a 
range of success rates for catheter ablation of AF from 56 - 89% (freedom from AF off anti-
arrhythmic drugs) compared to the use of AADs alone ranging from 4 - 43% (Camm, 
Kirchhof et al. ; Kannel, Abbott et al. 1982).  
Atrial tachycardia (AT) is relatively rare, accounting for 5-15% of all supraventricular 
tachycardias (SVTs). It can be encountered in patients with a structurally normal heart or those 
with underlying structural or scar-related heart disease. In patients with structurally normal 
hearts, atrial tachycardia is associated with a low mortality rate. However spontaneous 
resolution of symptomatic episodes is uncommon. Prolonged episodes (typically months or 
years) of continuous atrial tachycardia can be problematic leading to irreversible changes of 
the atria, including negative remodeling with atrial enlargement and myopathy causing 
symptomatic congestive cardiac failure. In addition, prolonged episodes can make reversion 
and maintenance of normal sinus rhythm more difficult. In recent years, the significance of AT 
in the initiation and perpetuation of atrial fibrillation has become apparent. Paradoxically AT 
occurs in up to 50% of patients undergoing extensive ablation for persistent AF.   
Sustained ventricular tachycardia (VT) is a significant cause of morbidity and sudden death 
especially in patients with underlying structural heart disease. Coronary heart disease is the 
most common cause of clinically documented VT occurring in 76–82% of the patients 
(CASCADE Study 1993; Kuch et al 2000; AVID Study 1997; CIDS Study 2000). Although 
implantable cardioverter defibrillators (ICD) prevent sudden cardiac death and antiarrhythmic 
drugs reduce the frequency of VT episodes, drug side-effects and repeated device therapies 
can have a major impact on quality of life (Moss et al 2004, Poole et al 2008, Schron et al 2002). 
Recurrent VT develops in 40-60% of patients receiving an ICD for ischaemic cardiomyopathy 
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after an episode of spontaneous sustained VT however the first ICD therapy appears to be the 
most important predictor of subsequent therapy in this population and is likely to occur 
within the first two years of implant (Koa-Wing M et al 2007). VT ablation has been shown to 
reduce therapies from ICDs, but in its current state, is technically challenging and time 
consuming with procedural times up to 8 hours (Cao et al 1996). 
1.2 The challenges of complex arrhythmias 
1.2.1 Atrial Fibrillation 
Several models have been proposed to explain the continuous irregular atrial activation of 
clinical AF. It is widely accepted that the initiation of AF is from an atrial ectopic ‘trigger’ 
originating from the pulmonary veins (Haissaguerre, Jais et al. 1998). The ‘trigger’ can continue 
to act as ‘a focal driver’ maintaining AF or can establish a self-sustaining spiral wave (or rotor) 
in a localised region of the myocardium leading to fibrillatory activation in the remaining atria 
(Haissaguerre, Jais et al. 1998; Jalife, Berenfeld et al. 2002; Sahadevan, Ryu et al. 2004).  
Pulmonary vein isolation to remove the ‘trigger’ has been shown to be effective in 
paroxysmal AF (Haissaguerre, Jais et al. 1998) (Pappone, Santinelli et al. 2004). However, 
triggers outside the pulmonary veins have also been identified in the superior vena cava 
and coronary sinus and these have been more challenging to identify and treat. Linear 
ablation has been performed in both paroxysmal and persistent AF along the principles of 
the Cox Maze surgical procedures, but these have not achieved the same success as the 
surgical approach (Cox, Boineau et al. 1995; Cox, Schuessler et al. 1996; Hsu, Jais et al. 2004).  
Linear ablation at the roof of the left atrium (Hocini, Jais et al. 2005) and the mitral isthmus 
between the left lower pulmonary vein and annulus has been shown to improve outcomes 
when there is proven conduction block of these lines (Jais, Hocini et al. 2004; Willems, 
Klemm et al. 2006). However, conduction block is difficult to achieve due to lack of catheter 
stability and failure to achieve transmurality.  
More recently, catheter-based substrate modification has targeted regions of highly 
fractionated electrograms that others suggest as drivers for persistent AF (Lellouche, Buch et 
al. 2007). Nadamanee et al achieved an 81% success rate for ablation after up to 4 procedures 
targeting only areas of complex fractionated atrial electrograms (CFAE) (Nademanee, 
Schwab et al. 2008). However several other groups have failed to reproduce these success 
rates with CFAE ablation alone (Estner, Hessling et al. 2008). Speculation as to the 
mechanistic basis for CFAE has implicated regions of autonomic innervations termed the 
ganglionated plexi, as these were noted to be co-located with regions of CFAE in animal 
studies. Alternatively, they may originate from regions of atrial scarring or fibrosis, and are 
thought to represent a combination of wavefronts approaching the recording electrode from 
multiple directions. Integration of delayed-enhancment MRI imaging, particularly 
containing information relating to scar, may provide greater insight on the origin of CFAE. 
This is discussed in more detail later in this chapter. 
Wide area circumferential ablation with pulmonary vein isolation, designed to encircle the PVs at 
a distance from the ostia, is a widely accepted technique for AF ablation and appears to achieve 
greater success rates than segmental PVI. (Marrouche, Martin et al. 2003; Pappone, Rosanio et al. 
2003; Ouyang, Bansch et al. 2004) The most widely practiced approach is to use a 3D-navigation 
system to recreate a virtual left atrium and move around the chamber delivering lesions around 
the pulmonary veins and marking lesion points on the virtual anatomy.(Pappone, Oreto et al. 
1999) The 3D geometry aids the operator in manipulating catheters around the complex anatomy 
of the left atrium which can vary significantly from patient to patient. This can prove particularly 
challenging with only 2D fluoroscopy for navigation.  
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Example of virtual left atrium and points marked (red balls) during wide area 
circumferential ablation 
Despite these novel approaches, published success rates for single procedure AF ablation 
range remain around 50% to 88% (Lim, Matsuo et al. 2007; Matsuo, Lim et al. 2007; Natale, 
Raviele et al. 2007; O'Neill, Jais et al. 2007; Marchlinski 2008) which are still not comparable 
to the >95% success rates expected from ablations for other arrhythmias.  
1.2.2 Atrial Tachycardia 
Endocardial activation allows categorisation of ATs into focal and macro-rentrant. However in 
the era of persistant AF ablation the presence of “micro-reentry” circuits particularly within 
regions of previous complex fractionated atrial electrograms (CFAE) ablation scar must be 
acknowledged. It is therefore imperative to clarify the mechanism of the underlying AT during 
electrophysiological procedures to guide ablation therapy. Currently established techniques 
for guiding ablation in complex atrial tachycardias include activation and/or entrainment 
mapping. Routinely the tachycardia is displayed as an activation map on a recreated atrial 
geometry from endocardial location points collected using 3-D mapping technology. However, 
activation mapping is limited by a point-by-point acquisition process which is not always 
systematic, is often time-consuming and can miss small areas crucial to the circuit.  Detailed 
mapping often requires >150-200 points with each circuit potentially involving multiple loops 
and figure-of-8 circuits.  In order to identify the critical isthmus maintaining the tachycardia a 
trained operator is required to set an accurate “window of interest” and collect activation data, 
which requires significant processing to ensure all collected points have been correctly 
annotated to the chosen reference. In addition conventionally established entrainment 
manoeuvres are often used to confirm the diagnosis represented by activation mapping 
however these can have limitations if there is a variation in the tachycardia cycle length 
particularly in scarred atria with multiple regions of block and slow conduction. 
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The most commonly recognised mechanisms seen post-AF ablation are macro re-entrant roof-
dependant and mitral isthmus dependant tachycardias however with increasing linear and 
CFAE ablation lesions, micro-reentrant circuits must also be appreciated. In these situations 
diagnostic yield from mapping and entrainment can test the most skilled electrophysiologist 
and although acute success rates have been reported ranging from 88-100%, recurrences are 
disappointing with rates ranging from 0-47% over a mean follow-up of 2 to 16 months 
(Gerstenfeld 2004; Chugh 2005; Deisenhofer 2006; Mesas 2004; Haïssaguerre 2005).  
Several other circuits capable of sustaining re-entrant tachycardias are seen following 
cardiac surgery, particularly congenital heart disease.    
These are typically a challenge to map and ablate due to the unpredictable location and 
extent of the underlying iatrogenic scar exposing the limitations of the aforementioned 
diagnostic techniques. 
1.2.3 Ventricular Tachycardia 
The biggest challenge in VT ablation remains scar-related VT including ischaemic and dilated 
cardiomyopathy. The substrate for post-infarct VT is produced by channels of slow conduction 
within the scar border (the diastolic pathway), created by anatomical and functional lines of 
block. Identification and ablation of these diastolic pathways is required for successful VT 
ablation (Koa-Wing, Ho SY et al 2007; Stevenson, Khan et al 1993). Conventional techniques to 
identify the diastolic pathway consist of performing activation mapping followed by entrainment 
manoeuvres to locate areas within the scar that participate in the re-entrant circuit (Stevenson, 
Khan et al 1993; Huang & Wood 2006; Bogun, Good et al 2006), but non-inducibility, difficulty 
capturing scarred myocardium during entrainment, multiple different morphologies of VT, 
haemodynamic instability and circuit components deep to the sub-endocardium make this 
approach unreliable and prolonged with disappointingly high recurrence rates. 
These limitations have led to a change in practice from targeting specific circuits to substrate 
modification of the scar by linear ablation in an attempt to transect potential diastolic 
pathways and render the VT non-inducible (Marchlinski, Callans et al 2000). Although acute 
ablation success rates at elimination of the “clinical” tachycardia have improved from 71-
74% (Morady et al 1993, Gonska et al 1994, Kim et al 1994) in the mid-1990s to 90% in the 
2000s (Sacher et al 2008) long-term outcomes remain unsatisfactory. This is despite the 
introduction of cardiac mapping systems, irrigated tip catheters and substrate based 
ablation strategies. Up to 31% of patients with an acutely successful ablation outcome of the 
“clinical” VT have arrhythmia recurrence. Ablation to non-inducibility of any VT has been 
reported with success rates approaching 65% but with recurrence rates of 29% during a 
median follow-up of 1 month (Sacher et al. 2008).  The potential causes of recurrence or 
failure at the index procedure include inadequate mapping techniques of, often small, 
isthmi in a complex anatomic substrate and failure to achieve transmurality of lesions in 
those with circuits traversing the subendocardium and epicardium. Although epicardial 
circuits can be targeted percutaneously, this is not possible in up to 85% of patients with 
previous cardiac surgery (Sacher F, Roberts-Thomson K, et al. 2010). 
2. Mapping 
The development of intra-cardiac mapping was based on the use of individual contact 
catheters. Despite being able to record information from different sites using multipolar 
catheters, complex arrhythmias and complex substrates pose significant challenges using 
these techniques. 3-D electrophysiological mapping systems were developed to aid the 
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localisation of the source of focal tachycardias and the critical isthmi of re-entrant circuits 
(Stevenson, Delacretaz et al 1998; Marchlinski, Callans et al 1998; Earley, Showkathali et al 
2006; Schilling, Peters et al 1999; Shah, Jais et al 1997) Conventionally, these systems display 
electrical data from mapping catheters as either local activation time (isochronal) or local 
voltage (isopotential) maps. These methods indicate the parameter being displayed using a 
colour-scale on a 3D representation of the cardiac chamber of interest.  
The current versions of these mapping systems are not only significantly more accurate but 
they offer many more features to facilitate mapping of complex arrhythmias; voltage 
mapping, propagation maps, rapid mapping using multipolar catheters and mapping of 
fractionated electrograms and the input of anatomical data from pre-operative CT or MRI 
scans of the heart or rotational angiograms. The latest feature allowing 4-dimensional 
mapping, ‘ripple-mapping’, will also be discussed in this chapter. 
The use of mapping systems has not been shown to reduce the duration of the procedure or 
the efficacy of the procedure(Sporton, Earley et al. 2004), however, it has been shown to 
significantly reduce the fluoroscopy time, thereby reducing the exposure of patients and lab 
staff to harmful radiation.(Scaglione, Biasco et al.) 
2.1 Current mapping systems 
Current electroanatomic mapping systems build a 3-dimensional geometry of a cardiac 
chamber by recording sequential positional co-ordinates from the catheter tip in contact 
with the myocardium and combining this information with concomitantly acquired 
electrogram data. Low voltage areas and scar can be easily identified to develop a picture of 
the underlying substrate for arrhythmogensis.  Electrogram timings with respect to a stable 
reference catheter, enables an activation map to be created, which is colour coded to 
differentiate between ‘early’ and ‘late’ signals. 
 
 
Colour coded activation map of a clockwise isthmus dependent right atrial flutter. 
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Alternatively, this can be displayed as a propagation map, which demonstrates activation of 
the excitatory wavefront as it advances across the chamber geometry. Maps can be rotated 
and viewed in multiple orientations at the same time so that the wavefront can be followed 
throughout the cardiac cycle. Electroanatomic mapping systems are primarily used for 
mapping stable tachycardias, however they can also facilitate substrate mapping during 
sinus rhythm, which is particularly useful when mapping VTs which cause significant 
haemodynamic compromise. Additionally, these systems facilitate encirclement of cardiac 
structures, the best example of which is the encirclement of pulmonary veins as part of the 
treatment for ablation of atrial fibrillation (AF).  Areas targeted may lie between important 
scar boundaries (e.g. linear ablation lesions to transect the diastolic pathway in VT circuits) 
or between inert structures (e.g. linear ablation between the mitral valve annulus and the 
left inferior pulmonary vein in mitral isthmus-dependent atrial tachycardia).  
2.2 Integration with robotic navigation 
New Cohesion™ 3D visualisation module available with the Hansen Robotic Navigation 
system allows integration of the electroanatomic mapping system NavX or Velocity (St Jude 
Medical™) This facilitates navigation of the robotic catheter by producing an intuitive 
driving plane according to the orientation of the virtual geometry within the mapping 
system. This removes the requirement for the operator to re-orientate him or herself when 
using the virtual geometry of the left atrium to guide navigation. This has been tested in 
clinical studies and shown to reduce fluoroscopy times for robotic navigation and ablation 
of AF.(Steven, Servatius et al. 2009) 
 
 
 
Example of Cohesion, Hansen Robotic navigation system fully integrated with NavX 
mapping system to provide intuitive driving in the orientation of the virtual LA geometry 
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2.3 Integration with MRI / CT imaging 
The CARTOTM and NavXTM systems can both integrate digital computed tomography (CT) 
or magnetic resonance imaging (MRI) images of the heart into a mapping study, allowing 
navigation of “virtual” catheters within a high resolution model of the patient’s anatomy. 
CT / MRI studies can either be imported and segmented via the image processing platforms 
available in both mapping systems, or can be segmented offline by an experienced operator 
for direct import to the mapping system at the time of the procedure. Registration of the 
segmented chamber to the patient orientation is performed using fluoroscopy. Fixed 
anatomical landmarks close to the chamber of interest are acquired and subsequently 
registered with their corresponding sites on the CT/MRI image. The identified landmarks 
are then “merged” together to complete the registration process so that the catheter tip can 
be navigated within the detailed anatomical shell created on CT / MRI. 
Electroanatomical mapping with CT/MRI image integration is particularly useful in 
patients with unusual or complex anatomy such as those with congenital heart disease and 
previous cardiac surgery. Detailed chamber anatomy is also helpful in pulmonary vein 
isolation procedures, by delineating the location, size and orientation of the pulmonary vein 
ostia. However, CT / MRI integration does not improve acute procedural efficacy or long 
term success rates.(Kistler, Rajappan et al. 2008)  
2.4 Imaging of myocardial scar and integration with mapping systems 
Delayed-enhanced Magnetic Resonance Imaging (DE-MRI) has been used for almost a 
decade to identify regions of ventricular scar. An increase in extracellular space within 
myocardial scar allows for an accumulation and prolonged wash-out time of the contrast 
agent, gadolinium.(Saraste, Nekolla et al. 2008). Information regarding ventricular or atrial 
scar can be obtained from voltage readings using intra-cardiac catheters. However, the 
integration of DE-MRI data may eliminate the need for acquisition of a detailed voltage 
map, and prevent inaccurate readings due to poor catheter contact.  
 
 
   
Example of similarity between endocardially collected voltage map and regions of LA scar 
identified by DE-MRI 
2.4.1 Ventricular scar in ischaemic VT 
DE-MRI enables detection, characterization and accurate quantification of acute and 
chronic myocardial infarction (Simonetti et al; McNamara et al 2001). Quantification of 
infarct size on DE-MRI has been validated against true infarct size as verified by 
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histochemical staining in animal models (Kim RJ et al 1999). Heterogeneous tissue 
surrounding areas with dense LGE are hypothesized to be the imaging equivalent of slow 
conduction zones in patients with ischemic cardiomyopathy (Yan AT, Shayne AJ et al. 
2006; Roes SD, Borleffs CJ et al 2009) although this is not a consistent finding. Until higher 
resolution images are possible we must accept the reality that the currently visualized 
“infarct core” and “heterogeneous tissue” is a mixture of true infarct core, true 
heterogeneous tissue, and artifacts, particularly those produced by volume averaging of 
infarct core with healthy tissue.  
Utilising the technique described by Yan et al, Perez-David et al. demonstrated the 
connection between heterogeneous tissue on CMR and slow conduction zones identified by 
endocardial mapping. Furthermore, they confirmed that sites identified as critical VT isthmi 
by electrophysiological manoeuvres often reside in heterogeneous tissue identified by CMR. 
2.4.2 Atrial scar in AF and AT 
More recently, as scanners and scanning quality have improved, attention has turned to 
visualising atrial myocardium, in particular looking for regions of pre-existing fibrosis and 
iatrogenic scar following catheter ablation procedures.(Kim, Hillenbrand et al. 2000; Kim, 
Wu et al. 2000) Several recent studies have shown that high-spatial-resolution delayed 
enhancement MR (DE-MRI) imaging allows identification of scar induced by RF ablation in 
the left atrium(Peters, Wylie et al. 2007; McGann, Kholmovski et al. 2008; Badger, Adjei-
Poku et al. 2009). Badger et al showed, however, that chronic atrial scar may not be formed 
and visible on MRI until up to 3 months following the ablation procedure. (Badger, Oakes et 
al. 2009)  Integration of data from DE-MRI regarding location of scarred regions may benefit 
procedures such as repeat AF ablations and post-ablation atrial tachycardias. In particular, it 
may help identify the location of gaps within lines which are providing the substrate for 
ongoing AF / AT. 
Methods for improved patient selection and non-invasive evaluation of the LA wall to 
assess the extent permanent tissue injury created by ablation, may be an important tool in 
improving ablation technique and increasing procedural success. Oakes et al demonstrated 
that the presence of left atrial fibrosis prior to ablation can also be detected using DE-MRI 
and that patients with higher levels of fibrosis had lower procedural success rates.(Oakes, 
Badger et al. 2009) On this basis they hypothesised that a further possible use of DE-MRI 
may be that of patient selection for atrial fibrillation ablation.  
2.5 Novel mapping systems: CARTO Ripple 
Despite the aforementioned advantages of current mapping systems there remain shortfalls 
and limitations to their use. The conversion of the raw electrical data to ‘clean’ activation 
maps requires operator expertise with the potential introduction of errors by incorrect 
assignment of local activation times or voltage thresholds. Furthermore interpolation of data 
within unmapped regions can lead to the display of false information. The introduction of 
integrated multielectrode mapping catheters should reduce this error by allowing creation 
of dense maps. This integration should also improve the rapidity with which maps are 
created with a likely increase in diagnostic yield (Patel et al 2008). Additionally, colour-
spectrum isochronal maps are often converted to propagation maps that display moving 
activation wave fronts that are interpreted more intuitively but are mathematically 
extrapolated from the points collected and can give the operator a false sense of the 
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resolution of the map. Isopotential maps created by grouping far-field reconstructed 
electrograms (Ensite Array) that are above a pre-specified activation threshold voltage to 
create activation wave fronts are prone to errors due to the subjective variation introduced 
by voltage threshold adjustments. In addition the hardware is limited by far-field 
reconstruction of low voltage electrograms.  
Intracardiac electrograms provide unique site-specific data about local electrical activation 
and in-vitro studies have demonstrated that underlying anatomical substrate can be 
deduced from the electrogram morphology (Spach MS, Miller WT et al 1979). Electrograms 
are categorised by largely binary descriptors; simple or complex, early or late, high or low 
amplitude. Potentially crucial information contained within electrograms is lost to 
interpretation with current 3D mapping systems. CARTO does not assign any characteristics 
to potentials (diastolic or late systolic) within ventricular scar and is unable to appropriately 
display valuable data contained within complex fractionated electrograms often 
representing regions of slow conduction which may play a pivotal role in scar related artial 
arrhythmias. As the system can only assign a single value for the local activation time, 
isochronal and activation maps can be flawed if complex fractionated electrogams are 
annotated incorrectly.  
ENSITE can collect simultaneous global activation data but is prone to far-field noise 
making low-amplitude fractionated signals difficult to differentiate from noise or 
repolarisation.  
 
 
The top panel shows increasing Ripple bar height in correlation to the increasing magnitude 
of the electrogram voltage in the annotation window (shown in the lower window).  
The bar height and colour are clearly visible. These can be correlated to the conventional 
reference colour bar from CARTO seen to the left of the panel with low voltage represented 
by red and high voltage represented by purple 
The conventional 2D method for displaying electrograms is deflection from a baseline 
according to a voltage scale. The overall sequence of directions and rates of change and 
amplitudes of deflections define the electrogram “morphology”. A new visualisation 
algorithm, Ripple Mapping, has allowed the reproduction of this 2D process on a 3D hull 
using a bar moving out from the cardiac surface conveying location, timing and electrogram 
morphology simultaneously (Linton, Koa-Wing. 2009). Multiple points collected in a small 
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area will display bars, which change according to the local voltage change and in a 
temporally accurate sequence producing a ‘ripple’ effect which conveys the direction of 
wave propagation without any operator annotation. The program avoids interpolation and 
as it does not use a single local activation time, all the components of the electrogram are 
preserved and displayed. Therefore a sequence of small potentials and complex 
electrograms can be temporally related to adjacent electrograms. This method has the 
benefit of using high quality contact electrograms capable of demonstrating low amplitude 
signals with accurate 3D localisation, enabling the assessment of electrogram morphology 
within scar. 
During the proof-of-concept study this novel method of cardiac mapping showed low-
amplitude continuous activity in four of five tachycardias at the site of successful ablation, 
consistent with a re-entrant mechanism. Cardiac Ripple Mapping has been integrated onto an 
off-line CARTO TM  platform, which is currently undergoing validation and clinical evaluation.  
 
 
 
Left panel: Displays a left atrial CARTO-XP local activation time (LAT) map of a patient 
with left atrial tachycardia following circumferential pulmonary vein isolation for 
paroxysmal atrial fibrillation. Analysis of the LAT map suggests the possibility of a focal 
tachycardia origination from the posterior wall near the right pulmonary veins.  
Right panel: The same atrial tachycardia as seen on the corresponding unaltered Ripple map 
(left lateral view) shows a roof dependant atrial tachycardia which was confimed by 
conventional entrainment manoeuvres. 
3. Ablation of complex arrhythmias 
The achievement of transmurality of ablation lesions for permanent VT abolition and 
pulmonary vein isolation is one of the ongoing challenges of ventricular tachycardia and 
atrial fibrillation ablation (Haissaguerre, Shah et al. 2000; Pappone, Santinelli et al. 
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2004);(Kosmidou, Inada et al. 2011 ; Willems, Steven et al. 2010). The Hansen robotic 
system was designed to improve catheter tip stability, lesion quality and clinical outcomes. 
3.1 The Hansen robotic navigation system 
The Hansen Sensei electromechanical robotic navigation system is capable of remotely 
steering a guide catheter to enable precise positioning and manipulation of any type of 
electrophysiological catheter within the heart for mapping and ablation. The Sensei system 
has been described in detail previously.(Saliba, Cummings et al. 2006; Kanagaratnam, Koa-
Wing et al. 2008)  In brief, the system comprises three linked components: the physician’s 
workstation (Sensei™ robotic control system), remote catheter manipulator (RCM) and 
steerable guide catheter (Artisan™ Sheath). The steerable guide catheter comprises an outer 
(14F) and inner (10.5F) steerable sheath through which any 8.5F or less ablation catheter can 
be placed. The outer guide can be inserted, deinserted and can bend up to 90 degrees, 
whereas the inner guide is controlled by the 3D joystick and can be directed anywhere 
within the toroidal workspace. The Artisan sheath maintains the catheter position by the 
tensile strength of four pullwires so that the shape adopted by the sheath is uniquely suited 
to the point of interest to which the catheter is being positioned.(Kanagaratnam, Koa-Wing 
et al. 2008) This is in contrast to the manual approach, where the operator has to 
dynamically apply torque and flexion to prevent the catheter displacing from the point of 
interest. The Sensei™ robotic control system also incorporates a pressure sensor 
(Intellisense™), which calculates the contact force at the tip of the catheter using the 
differential resistance when continuously dithering the catheter in and out of the Artisan 
sheath. This tissue contact pressure enhances the validation of tissue contact and also 
provides for the ability to identify a pressure curve for optimal lesion production. 
(Kanagaratnam, Koa-Wing et al. 2008) 
 
 
 
Hansen Robotic Artisan steerable sheath.  
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The Sensei system is currently compatible with all 8.5F or less mapping and irrigated 
ablation catheters. The physicians work station comprises 3 screens which can display any 
selected data including fluoroscopy, intracardiac echocardiography, electroanatomic 
mapping systems (Carto Biosense Webster, NavX St Jude Medical, Rotational Angiography 
imaging Philips ElectroNav etc.), and electrogram display systems (Bard Lab System Pro 
etc.) The free standing physician’s work station and remote catheter manipulation system 
mounted on the patient table can be moved between laboratories and do not require any 
floor reinforcement such as that required for magnetic remote navigation systems. 
The intended benefit of robotic catheter manipulation is that the catheter position is 
maintained once the physician has released the 3D joystick providing increased stability 
throughout the duration of RF delivery. In addition, the Intellisense system can confirm 
catheter contact during ablation.  
3.1.1 Atrial and ventricular ablation 
Several studies have been performed in animals to investigate whether the theoretical benefits 
of robotic ablation are translated into improved measurable parameters of lesion quality. In a 
study comparing robotic (Sensei) and manual ablation in 7 pig atria, robotic ablation reduced 
local electrogram amplitude to a greater degree than manual ablation (49+/- 2.6% vs 29 +/- 
4.5% signal reduction after one minute p=0.0002) The incidence of >50% signal reduction was 
also greater for robotic (37%) than manual (21%) (p=0.0001).(Koa-Wing, Kojodjojo et al. 2009) 
Koa-Wing et al also noted that macroscopically the robotic lesions were more consistently 
transmural compared to the manual lesions, with no evidence of charring or perforation with 
either modality. In other in-vitro studies, 45W at 20-30g for 40secs, 83% of lesions were 
transmural, however 33% of lesions were associated with char formation. Using 30W and 20-
30g pressure 0% were associated with char formation, however only 16% were associated with 
transmural lesion formation. (Di Biase, Natale et al. 2009), 
Previous human studies comparing robotic and manual ablation have been non-randomised 
and have shown no significant difference in clinical outcomes. The primary aim of these 
studies was to prove safety and feasibility, however it is important to try to understand the 
potential reasons why these studies did not deliver the anticipated benefits of increased 
catheter precision and stability. (Willems, Steven et al 2010; Di Biase, Wang et al. 2009)  The 
two studies both quoted using the same settings for both robotic and manual ablation (45W 
for 20secs and 20-25W for 60s) lesions. Interestingly, both reports comment on how robotic 
ablation required shorter radiofrequency duration. Therefore, in both series it appears that 
operators adjusted power according to anatomical location and local signal attenuation. 
Therefore, if the same target was being used for both manual and robotic arms, it is 
unsurprising that the clinical outcomes were similar.  
The ability to titrate force and improve tissue contact are important attributes required 
during ablation in the ventricle which can be over a centimetre thick. Furthermore greater 
transmurality of delivered lesions should negate the need to gain epicardial access in this 
patient population who have often previously undergone cardiac surgery, making 
percutaneous access less practical. The reduction in operator radiation exposure during 
these long procedures is of added value. There are no large scale trials of robotic VT ablation 
however acute feasibility is suggested by occasional single case reports (Duncan, Johns et al 
2010; Koa-Wing, Linton et al. 2009) Larger scale studies should help clarify the role of this 
technology in ablation of complex arrhythmias.  
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4. Conclusion 
With the rapidly progressing field of catheter ablation, advances in mapping and ablation 
technologies will lead to improved therapeutic outcomes in complex cardiac arrhythmias. 
Innovative methods of assessing, displaying and integrating the underlying substrate of 
complex scar with electrophysiological data will further streamline our current practice in 
these challenging cases.  
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